Unusual Machines Inc
For the period ended Sep 30, 2024. Filed Nov 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 14, 2024
UMAC$12.59-6.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Consolidated Condensed Balance Sheets
Consolidated Condensed Balance Sheets
| September 30, 2024 | December 31, 2023 | |
|---|---|---|
| (Unaudited) | ||
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $1,685,772 | $894,773 |
| Accounts Receivable | 79,907 | – |
| Inventory | 1,453,042 | – |
| Prepaid inventory | 1,140,511 | – |
| Other current assets | 158,093 | 120,631 |
| Total current assets | 4,517,325 | 1,015,404 |
| Non-current assets: | ||
| Property and equipment, net | 741 | 1,254 |
| Deferred offering costs | – | 512,758 |
| Operating lease right-of-use assets | 340,389 | – |
| Goodwill and intangible assets | 19,666,086 | – |
| Total non-current assets | 20,007,216 | 514,012 |
| Total assets | $24,524,541 | $1,529,416 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities | ||
| Accounts payable and accrued expenses | $1,032,636 | $114,497 |
| Operating lease liabilities | 65,089 | – |
| Deferred revenue | 300,517 | – |
| Warrant liabilities | 308,964 | – |
| Derivative liability – convertible note conversion option | 311,048 | – |
| Total current liabilities | 2,018,254 | 114,497 |
| Long-term liabilities | ||
| Convertible note | 3,000,000 | – |
| Operating lease liabilities – long term | 280,285 | – |
| Total liabilities | 5,298,539 | 114,497 |
| Commitments and contingencies (See note 13) | – | |
| Stockholders’ equity: | ||
| Series A preferred stock - $0.01 par value, 4,250 authorized and 4,250 and 0 shares issued and outstanding on September 30, 2024 and December 31, 2023, respectively | 43 | – |
| Series B preferred stock - $0.01 par value, 10,000,000 authorized and 50 and 190 shares issued and outstanding on September 30, 2024 and December 31, 2023, respectively | 1 | 2 |
| Series C preferred stock - $0.01 par value, 3,000 authorized and 210 and 0 shares issued and outstanding on September 30, 2024 and December 31, 2023, respectively | 2 | – |
| Common stock - $0.01 par value, 500,000,000 authorized and 6,184,983 and 3,217,255 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively | 61,850 | 32,173 |
| Additional paid in capital | 27,959,642 | 5,315,790 |
| Accumulated deficit | (8,795,536) | (3,933,046) |
| Total stockholders’ equity | 19,226,002 | 1,414,919 |
| Total liabilities and stockholders’ equity | $24,524,541 | $1,529,416 |
See accompanying condensed unaudited notes to the consolidated condensed financial statements.** **
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.